651 filings
Page 12 of 33
8-K
ynebxcjpohj6t4g3
15 May 18
Vaxart Announces First Quarter 2018 Financial Results
12:00am
8-K
vmgkhuc6ayftn34vi
13 Apr 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K/A
469m40e0wmpown6garin
2 Apr 18
Financial Statements and Exhibits
12:00am
DEFA14A
qh0f 2oj5xtssox
26 Feb 18
Additional proxy soliciting materials
12:00am
8-K
qult8my53 0qpo
20 Feb 18
Combined Company Renamed Vaxart, Inc. and Will Begin Trading
12:00am
CORRESP
48kqimlk dpd6pvw
9 Feb 18
Correspondence with SEC
12:00am
8-K
0une1c nbad0kpamll
9 Feb 18
Aviragen Adjourns Special Meeting of Stockholders to Allow Stockholders to Consider Improved Merger Deal Terms
12:00am
425
3nvzj88
9 Feb 18
Business combination disclosure
12:00am
425
qf1qorfvqxn8oxi1oaf
9 Feb 18
Business combination disclosure
12:00am
DFAN14A
yrbrgb55zgx04j9v6
9 Feb 18
Additional proxy materials by non-management
12:00am
425
4dvnb4b8po36rco9kgc
7 Feb 18
Business combination disclosure
12:00am
8-K
cx0pr
7 Feb 18
Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders
12:00am
8-K
uccoequappbx 845zjxx
6 Feb 18
Aviragen Adjourns Special Meeting of Stockholders Until February 9, 2018
12:00am
425
ps15 lnmibbudblcb
6 Feb 18
Business combination disclosure
12:00am
8-K
gxyanll
1 Feb 18
Aviragen Provides New Information Supporting Vote FOR Vaxart Merger
12:00am
425
hno9b87 jljre
1 Feb 18
Business combination disclosure
12:00am
425
bnbgagpcr9d 8r40
1 Feb 18
Business combination disclosure
12:00am